Nuveen Credit Opportunities 2022 Target Term Fund JCO
7.95 0.00 (+0.00%)
May 25, 2022, 3:41 PM EDT
7.94 Day range 7.96
7.94 52-week range 7.96
- Market cap
- 220.81M
- Volume
- 38.34K
- Open
- 7.94
- Previous close
- 7.95
- Day's range
- 7.94 – 7.96
- 52-week range
- 7.94 – 7.96
No chart data for this range yet.
Key statistics
- Price / sales
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- 50-day average
- 7.95
- 200-day average
- 7.95
Next earnings
Consensus EPS estimate 0.00.
News
RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) pivotal data show strong and durable responses in advanced head and neck cancer where options remain limited 
Daily Journal Corp. (S.C.) (NASDAQ:DJCO) and American Community Newspapers (OTCMKTS:ACNI) Critical Review 
Results of GRAIL's Galleri® Multi-Cancer Early Detection Blood Test in Prostate Cancer Published in JCO Precision Oncology 
Innovent Announces Taletrectinib（ROS1 Inhibitor）Updated Data from Pivotal Phase 2 TRUST-I Study of are Published in the JCO and Orally Presentedat 2024 ASCO Annual Meeting 
Innovent Announces Data from Pivotal Phase 2 TRUST-I Study of Taletrectinib（ROS1 Inhibitor) are Published in the JCO and Reported at 2024 ASCO Annual Meeting 
New Study Published in JCO Precision Oncology Shows Myriad Genetics' Prolaris Test Can Predict Benefit of Hormone Therapy Treatment in Men with Localized Prostate Cancer 
Nuveen Credit Opportunities 2022 Target Term Fund Announces Termination and Liquidation 
Nuveen Credit Opportunities 2022 Target Term Fund Declares Special Distribution 
Stocks That Hit 52-Week Lows On Tuesday 
Nuveen Credit Opportunities 2022 Target Term Fund Announces Liquidation Details
Your note
Sign in to keep a note on JCO — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| MEYERS WILLIAM T. | Officer | Purchase | Oct 14, 2018 | 722 |
| NUVEEN FUND ADVISORS, L.L.C. | Investment Advisor | Sale | Jan 11, 2021 | 0 |